70-640 exam 70-642 exam 70-643 exam 70-647 exam 70-680 exam 70-432 exam 70-450 exam 70-646 exam 70-410 exam 70-411 exam 70-412 exam 70-461 exam 70-462 exam 70-463 exam 70-466 exam 70-467 exam 70-413 exam 70-414 exam 1Z0-051 exam 1Z0-052 exam 1Z0-053 exam 1z0-042 exam 1z0-047 exam 1z0-043 exam 1Z0-144 exam 1Z0-146 exam 642-902 exam 642-832 exam 642-813 exam 642-427 exam 642-437 exam 642-447 exam 642-457 exam 642-467 exam 300-206 exam 300-207 exam 300-208 exam 300-209 exam C4040-108 exam C4040-109 exam C4040-221 exam C4090-451 exam C4040-332 exam 220-701 exam 220-702 exam LX0-101 exam LX0-102 exam HP0-P20 exam HP0-P19 exam HP0-P21 exam 700-505 640-911 M70-301 70-489 700-501 M70-101 70-458 70-341 70-464 70-680 74-335 70-687 70-457 n10-005 1z0-061 220-801 70-465 exam C4090-958 MB2-867J MB2-868 MB2-876 MB3-207 MB3-208 MB3-209 MB3-210 MB3-214 MB3-215 MB3-216 MB3-230 P2060-001 P2060-002 P2060-017 P2070-055 P2070-071 P2070-072 VCAW510 VCP-310 VCP-410 VCP-411 VCP-510 VCP-511 VCP-550 1Z1-821 1Z1-822 1Z1-850 1Z1-851 74-353 74-404 74-409 74-674 74-676 70-410 70-460 70-461 70-462 200-120 70-488 MB2-703 70-411 mb5-705 70-346 70-486 70-347 70-480 70-483 70-412 70-463 mb2-700 3X0-203 3X0-204 400-051 400-101 500-005 500-051 500-201 500-254 500-285 510-014 510-015 810-420 820-421 820-422 83-640 850-001 920-093 A2040-986 A2040-988 A2050-219 A2050-723 BR0-002 BR0-003 C_A1FIN_10 C_BOCR_08 CX-310-019 CX-310-027 CX-310-052 CX-310-053 MB2-498 MB2-631 MB2-632 MB2-633 MB2-634 MB2-700 MB2-701 MB2-702 MB2-703 MB2-866 MB2-867 windows 7 key windows 7 key windows 7 key windows 7 key Windows-8-Enterprise-Key Windows-8-Enterprise-Key-sale cheap-Windows-8-Key Windows-8-1-Key Windows-8-Standard-Key Windows-8-Standard-Key-online buy-Windows-8-Standard-Key windows-7-key buy-windows-7-key windows-7-key-sale cheap-windows-7-key-for-sale windows-7-key-sale-oem windows-7-key-sale-finmde buy-Windows-8-Key windows-7-key-for-sale cheap-windows-7-key-sale windows-7-ultimate-serial-product 18630-product-key-number windows-7-all-number windows-7-product-keys windows-8-professional-product-keys windows-8-product-keys-serial-keys windows-8-professional-product-key windows-8-product-key Office-2013-Professional-Key Office-2010-Professional-Key windows81-product-key Office-2013-Professional-Key Office-2010-Professional-Key windows 7 key windows 7 key windows 8 key windows 7 key windows 7 key windows 7 key windows 7 key windows 8 key windows 8 key windows 8 key windows 8 key windows 8 key windows 8.1 key windows 7 key windows 7 key windows 7 key windows 7 key windows 7 key
NeuroHealing Pharmaceuticals Appoints Josh Hamermesh to Board of Directors - EWORLDWIRE

Why EworldwireTM

Get Direct Delivery : Send your press release via the highest regarded and respected PR newswire service. All media targeting services - from writing, to video, podcast and photo - are provided in-house by the ONLY BUSINESS WIRE TO OFFER THESE SERVICES COMPLETELY IN-HOUSE. ARCHIVE YOUR PRESS RELEASE INDEFINITELY - NOT JUST 7 OR 30 DAYS- and benefit from the long-term long tail impact of your news release when the public is searching online, with no hidden costs.

Login

logo

NeuroHealing Pharmaceuticals Inc.
Internet:
info@neurohealing.com
http://www.neurohealing.com

Company Information :
NeuroHealing Pharmaceuticals Inc.
PO Box 238
Waban, MA 02468
USA
Ph. 617.965.0872

NeuroHealing Pharmaceuticals Appoints Josh Hamermesh to Board of Directors

For Immediate Release

NEWTON, Mass./EWORLDWIRE/June 30, 2014 --- NeuroHealing Pharmaceuticals Inc., a private clinical stage company developing drug treatments for individuals with neuro-rehabilitation needs, today announced the addition of Josh Hamermesh to the company's Board of Directors.

Josh Hamermesh has over 15 years of operating, start up, and consulting experience in the life sciences industry. He is currently a vice president at Locust Walk Partners, a transaction advisory firm that supports biopharmaceutical companies, working with clients to support their business development and financing initiatives.

Previously, Hamermesh was vice president, Business & Corporate Development at Infinity Pharmaceuticals, where he was responsible for the company's in-licensing, out-licensing and alliance management activities. Prior to Infinity, he held the position of senior vice president, Strategy & Corporate Development at Pervasis Therapeutics, where he led strategic partnering initiatives for the company's product development portfolio. Hamermesh also served as vice president, Commercial & Business Development at Molecular Insight Pharmaceuticals, where he completed multiple in-licensing transactions and supported the company's initial public offering. His biotech career began at Genzyme, where he served as chief operating officer of MG Biotherapeutics, a joint venture with Medtronic, after holding positions of increasing responsibility in marketing and business development.

Prior to joining the life science industry, Hamermesh worked as a business strategy consultant at the Monitor Company. He holds a B.A., magna cum laude, from Amherst College, and an M.B.A. from Harvard Business School. Hamermesh has completed Boston and New York marathons, coaches multiple youth sports teams, played professional basketball in the Israel national league, and has held leadership roles in local school and philanthropic organizations.

"On behalf of the Board, I'm very pleased to welcome Josh Hamermesh as a new director of NeuroHealing. We believe that Josh's business savvy, integrity and strategic planning in several biopharmaceutical companies at a similar stage as NeuroHealing will prove very valuable," said Neal M. Farber, Ph.D., CEO of NeuroHealing. "We look forward to working with Josh and benefiting from his experience and judgment."

Mr. Hamermesh commented, "It's an exciting time to join NeuroHealing's Board of Directors, and I look forward to working with the team. With a continued focus on repositioning neurologically active compounds for important, specialty indications, the company is well positioned to deliver important new medicines to patients."

About NeuroHealing Pharmaceuticals Inc. (http://www.NeuroHealing.com)
NeuroHealing Pharmaceuticals Inc. is a clinical stage private company developing innovative treatments for specialty indications based on repositioning neurologically active compounds. Clinical stage programs include:

- NH001 (phase II), a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative or minimally consciousness state.
- NH004 (phase II), an anticholinergic agent in convenient thin film delivery to help treat Parkinsons and other patients with movement disorders suffering from sialorrhea (drooling).
- NH02D, a neurologically active compound to treat premature ejaculation.

HTML:   http://www.eworldwire.com/pressreleases/212972
PDF:   http://www.eworldwire.com/pdf/212972.pdf
MOBILE:    http://www.eworldwire.com/mobile/212972
ONLINE NEWSROOM:   http://www.eworldwire.com/newsroom/305366.htm

NEWSROOM RSS FEED:   http://newsroom.eworldwire.com/xml/newsrooms/305366.xml
LOGO:   http://www.eworldwire.com/newsroom/305366.htm

CONTACT:
Neal M. Farber
NeuroHealing Pharmaceuticals, Inc.
PO Box 238
Waban, MA 02468
PHONE. 6179650872
EMAIL: neal@neurohealing.com
http://www.neurohealing.com

KEYWORDS: drug research, biotech, biotechnology, NeuroHealing Pharmaceuticals Inc., Pharmaceuticals, neurology, board of directors, clinical trials

SOURCE: NeuroHealing Pharmaceuticals Inc.


(Top)

    • Featured

  • Client Login

    Forgot Password?
  • Newsletter